2 New classes of medications, such as the dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose cotransporter- 2 (SGLT-2) inhibitors, specifically target some of the more recently identified defects described in the ominous octet to help manage uncontrolled hyperglycemia
51% for insulin glargine
Keeping an eye on how its going and making changes is key to success
The goal is not weight loss but rather getting your body accustomed to the medication
Management Strategies Licensed providers often recommend small, frequent meals rather than three large ones
Klow Peptide Blend - A Smarter Way to Combine Peptides The Klow blend peptide is a quad-peptide formulation that includes the full composition of the Glow formula (BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg)), plus KPV (10 mg), totaling 80 mg per vial